Fabrizio Vecchio1, Francesca Miraglia1,2, Francesco Iberite1, Giordano Lacidogna3, Valeria Guglielmi3, Camillo Marra2,3, Patrizio Pasqualetti4, Francesco Danilo Tiziano5, Paolo Maria Rossini2,6. 1. Brain Connectivity Laboratory, IRCCS San Raffaele Pisana. 2. Institute of Neurology, Area of Neuroscience, Catholic University of The Sacred Heart. 3. Neuropsychological Center, Catholic University of The Sacred Heart. 4. Service of Medical Statistics and Information Technology, Fatebenefratelli Foundation for Health Research and Education, AFaR Division. 5. Institute of Medical Genetics, Catholic University, Policlinic A. Gemelli Foundation. 6. Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.
Abstract
OBJECTIVE: Mild cognitive impairment (MCI) is a condition intermediate between physiological brain aging and dementia. Amnesic-MCI (aMCI) subjects progress to dementia (typically to Alzheimer-Dementia = AD) at an annual rate which is 20 times higher than that of cognitively intact elderly. The present study aims to investigate whether EEG network Small World properties (SW) combined with Apo-E genotyping, could reliably discriminate aMCI subjects who will convert to AD after approximately a year. METHODS: 145 aMCI subjects were divided into two sub-groups and, according to the clinical follow-up, were classified as Converted to AD (C-MCI, 71) or Stable (S-MCI, 74). RESULTS: Results showed significant differences in SW in delta, alpha1, alpha2, beta2, gamma bands, with C-MCI in the baseline similar to AD. Receiver Operating Characteristic(ROC) curve, based on a first-order polynomial regression of SW, showed 57% sensitivity, 66% specificity and 61% accuracy(area under the curve: AUC=0.64). In 97 out of 145 MCI, Apo-E allele testing was also available. Combining this genetic risk factor with Small Word EEG, results showed: 96.7% sensitivity, 86% specificity and 91.7% accuracy(AUC=0.97). Moreover, using only the Small World values in these 97 subjects, the ROC showed an AUC of 0.63; the resulting classifier presented 50% sensitivity, 69% specificity and 59.6% accuracy. When different types of EEG analysis (power density spectrum) were tested, the accuracy levels were lower (68.86%). INTERPRETATION: Concluding, this innovative EEG analysis, in combination with a genetic test (both low-cost and widely available), could evaluate on an individual basis with great precision the risk of MCI progression. This evaluation could then be used to screen large populations and quickly identify aMCI in a prodromal stage of dementia. Ann Neurol 2018 Ann Neurol 2018;84:302-314.
OBJECTIVE: Mild cognitive impairment (MCI) is a condition intermediate between physiological brain aging and dementia. Amnesic-MCI (aMCI) subjects progress to dementia (typically to Alzheimer-Dementia = AD) at an annual rate which is 20 times higher than that of cognitively intact elderly. The present study aims to investigate whether EEG network Small World properties (SW) combined with Apo-E genotyping, could reliably discriminate aMCI subjects who will convert to AD after approximately a year. METHODS: 145 aMCI subjects were divided into two sub-groups and, according to the clinical follow-up, were classified as Converted to AD (C-MCI, 71) or Stable (S-MCI, 74). RESULTS: Results showed significant differences in SW in delta, alpha1, alpha2, beta2, gamma bands, with C-MCI in the baseline similar to AD. Receiver Operating Characteristic(ROC) curve, based on a first-order polynomial regression of SW, showed 57% sensitivity, 66% specificity and 61% accuracy(area under the curve: AUC=0.64). In 97 out of 145 MCI, Apo-E allele testing was also available. Combining this genetic risk factor with Small Word EEG, results showed: 96.7% sensitivity, 86% specificity and 91.7% accuracy(AUC=0.97). Moreover, using only the Small World values in these 97 subjects, the ROC showed an AUC of 0.63; the resulting classifier presented 50% sensitivity, 69% specificity and 59.6% accuracy. When different types of EEG analysis (power density spectrum) were tested, the accuracy levels were lower (68.86%). INTERPRETATION: Concluding, this innovative EEG analysis, in combination with a genetic test (both low-cost and widely available), could evaluate on an individual basis with great precision the risk of MCI progression. This evaluation could then be used to screen large populations and quickly identify aMCI in a prodromal stage of dementia. Ann Neurol 2018 Ann Neurol 2018;84:302-314.
Authors: Sara Cocco; Marco Rinaudo; Salvatore Fusco; Valentina Longo; Katia Gironi; Pietro Renna; Giuseppe Aceto; Alessia Mastrodonato; Domenica Donatella Li Puma; Maria Vittoria Podda; Claudio Grassi Journal: Front Cell Dev Biol Date: 2020-07-03
Authors: Linda Douw; Edwin van Dellen; Alida A Gouw; Alessandra Griffa; Willem de Haan; Martijn van den Heuvel; Arjan Hillebrand; Piet Van Mieghem; Ida A Nissen; Willem M Otte; Yael D Reijmer; Menno M Schoonheim; Mario Senden; Elisabeth C W van Straaten; Betty M Tijms; Prejaas Tewarie; Cornelis J Stam Journal: Netw Neurosci Date: 2019-09-01
Authors: Claudio Babiloni; Giuseppe Noce; Carlo Di Bonaventura; Roberta Lizio; Maria Teresa Pascarelli; Federico Tucci; Andrea Soricelli; Raffaele Ferri; Flavio Nobili; Francesco Famà; Eleonora Palma; Pierangelo Cifelli; Moira Marizzoni; Fabrizio Stocchi; Giovanni B Frisoni; Claudio Del Percio Journal: Front Neurol Date: 2020-10-23 Impact factor: 4.003
Authors: Alfie R Wearn; Esther Saunders-Jennings; Volkan Nurdal; Emma Hadley; Michael J Knight; Margaret Newson; Risto A Kauppinen; Elizabeth J Coulthard Journal: Alzheimers Res Ther Date: 2020-09-28 Impact factor: 6.982